1. Home
  2. CLSD vs VTSI Comparison

CLSD vs VTSI Comparison

Compare CLSD & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • VTSI
  • Stock Information
  • Founded
  • CLSD 2011
  • VTSI 1993
  • Country
  • CLSD United States
  • VTSI United States
  • Employees
  • CLSD N/A
  • VTSI N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • CLSD Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • CLSD Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • CLSD 68.4M
  • VTSI 67.3M
  • IPO Year
  • CLSD 2016
  • VTSI N/A
  • Fundamental
  • Price
  • CLSD $0.46
  • VTSI $6.14
  • Analyst Decision
  • CLSD Hold
  • VTSI Strong Buy
  • Analyst Count
  • CLSD 4
  • VTSI 1
  • Target Price
  • CLSD $4.33
  • VTSI $7.00
  • AVG Volume (30 Days)
  • CLSD 12.7M
  • VTSI 84.6K
  • Earning Date
  • CLSD 08-11-2025
  • VTSI 08-11-2025
  • Dividend Yield
  • CLSD N/A
  • VTSI N/A
  • EPS Growth
  • CLSD N/A
  • VTSI N/A
  • EPS
  • CLSD N/A
  • VTSI 0.19
  • Revenue
  • CLSD $3,764,000.00
  • VTSI $26,164,645.00
  • Revenue This Year
  • CLSD $143.33
  • VTSI $9.92
  • Revenue Next Year
  • CLSD N/A
  • VTSI $16.54
  • P/E Ratio
  • CLSD N/A
  • VTSI $32.50
  • Revenue Growth
  • CLSD N/A
  • VTSI N/A
  • 52 Week Low
  • CLSD $0.29
  • VTSI $3.57
  • 52 Week High
  • CLSD $1.65
  • VTSI $8.98
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 34.58
  • VTSI 50.36
  • Support Level
  • CLSD $0.29
  • VTSI $5.81
  • Resistance Level
  • CLSD $0.62
  • VTSI $6.31
  • Average True Range (ATR)
  • CLSD 0.11
  • VTSI 0.26
  • MACD
  • CLSD -0.02
  • VTSI -0.02
  • Stochastic Oscillator
  • CLSD 25.16
  • VTSI 50.60

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: